National Technical Advisory Group on Immunisation (India)

National Technical Advisory Group on Immunisation (India)
Name	National Technical Advisory Group on Immunisation (India)
Abbreviation	NTAGI
Formation	2001
Type	Advisory body
Headquarters	New Delhi
Leader title	Chairperson
Parent organization	Ministry of Health and Family Welfare
Region served	India

National Technical Advisory Group on Immunisation (India) The National Technical Advisory Group on Immunisation (NTAGI) is India's apex technical advisory body on immunization and vaccine policy, advising the Ministry of Health and Family Welfare (India) and coordinating with state and national programs. It provides evidence-based recommendations drawing on expertise from institutions such as the Indian Council of Medical Research, All India Institute of Medical Sciences, National Institute of Virology, and international partners including the World Health Organization and United Nations Children's Fund.

History and Establishment

NTAGI was constituted in 2001 following deliberations within the Ministry of Health and Family Welfare (India) and inputs from the World Health Organization and the United Nations Children's Fund to strengthen decision-making for the Universal Immunization Programme (India). Its establishment was influenced by prior vaccine policy debates involving stakeholders like the Planning Commission (India), National Technical Advisory Group-style models from United Kingdom, United States, and recommendations from the Global Alliance for Vaccines and Immunization. NTAGI's early years collaborated with research bodies including the Indian Council of Medical Research, National Institute of Immunology, and clinical centers such as Christian Medical College Vellore and Postgraduate Institute of Medical Education and Research.

Mandate and Functions

NTAGI's mandate includes reviewing scientific evidence on vaccine safety, efficacy, and cost-effectiveness and advising the Ministry of Health and Family Welfare (India) on introduction of new vaccines into the Universal Immunization Programme (India). It evaluates data from agencies such as the National Technical Research Organisation and surveillance networks including the Integrated Disease Surveillance Programme (India), and issues recommendations that inform procurement by entities like the Central Drugs Standard Control Organization and budgeting through the Ministry of Finance (India). NTAGI also formulates guidance aligned with standards from the World Health Organization Strategic Advisory Group of Experts on Immunization and interfaces with manufacturers such as Bharat Biotech, Serum Institute of India, and international suppliers.

Membership and Governance

NTAGI comprises experts nominated from academic institutions such as All India Institute of Medical Sciences, Indian Council of Medical Research, National Institute of Virology, Tata Memorial Centre, and public health schools like Public Health Foundation of India. Members include clinicians, epidemiologists, vaccinologists, and health economists drawn from entities including Christian Medical College Vellore, Postgraduate Institute of Medical Education and Research, National Centre for Disease Control, and state health departments like the Delhi Directorate of Health Services. Governance mechanisms involve periodic meetings convened by the Ministry of Health and Family Welfare (India), with secretariat support from agencies such as the National Health Mission and technical inputs from World Health Organization country office experts.

Role in Vaccine Policy and Recommendations

NTAGI provides formal recommendations on vaccine introduction, schedule changes, and age-group targeting, impacting programs such as introduction of rotavirus vaccine, pneumococcal conjugate vaccine, and human papillomavirus vaccine into the Universal Immunization Programme (India). It assesses data from clinical trials at institutions like Christian Medical College Vellore, post-marketing surveillance by the Central Drugs Standard Control Organization, and epidemiological studies from the Indian Council of Medical Research to recommend vaccine policy aligned with global guidance from the World Health Organization and funding considerations involving the Ministry of Finance (India) and international partners like Gavi, the Vaccine Alliance.

Interaction with National and International Bodies

NTAGI routinely interacts with national entities including the Ministry of Health and Family Welfare (India), National Health Mission, Central Drugs Standard Control Organization, and state health departments. International collaboration includes coordination with the World Health Organization, United Nations Children's Fund, Gavi, the Vaccine Alliance, and research partnerships with institutions such as the London School of Hygiene & Tropical Medicine and the Centers for Disease Control and Prevention. It also engages with manufacturers like Serum Institute of India and Bharat Biotech and funding stakeholders including the Bill & Melinda Gates Foundation.

Impact and Key Contributions

NTAGI's recommendations have guided major programmatic shifts including phased introduction of the rotavirus vaccine, pneumococcal conjugate vaccine, and expanded use of the measles-rubella vaccine in mass campaigns coordinated with the National Polio Surveillance Project and state immunization drives in Uttar Pradesh, Bihar, and Maharashtra. It influenced policy responses during outbreaks monitored by the National Centre for Disease Control and informed COVID-19 vaccine prioritization frameworks aligning with World Health Organization guidance and national rollout managed by the Ministry of Health and Family Welfare (India). NTAGI's health economic assessments and safety reviews affected procurement decisions involving Serum Institute of India, Bharat Biotech, and global suppliers, and shaped training curricula at institutions like the Public Health Foundation of India.

Criticisms and Challenges

NTAGI has faced critique regarding transparency, frequency of public disclosures, and perceived delays in recommendation timelines, raised by media outlets, civil society organizations, and some academic centers including commentators from All India Institute of Medical Sciences and Indian Council of Medical Research-affiliated researchers. Challenges include coordination across federal and state bodies such as National Health Mission and state health departments in Kerala and Rajasthan, balancing domestic manufacturing capacities at firms like Serum Institute of India with global supply constraints, and integrating rapidly evolving evidence during emergencies as seen during the COVID-19 pandemic and meningitis outbreaks monitored by the National Centre for Disease Control.

Category:Medical and health organisations based in India Category:Vaccination in India